These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1178807)

  • 21. Antiparkinsonian agents and depot phenothiazine.
    Chien CP; Dimascio A; Cole JO
    Am J Psychiatry; 1974 Jan; 131(1):86-90. PubMed ID: 4808437
    [No Abstract]   [Full Text] [Related]  

  • 22. [Double-blind study of domestic penfluridol and fluphenazine decanoate].
    Shu L
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1983 Jun; 16(3):141-5. PubMed ID: 6653230
    [No Abstract]   [Full Text] [Related]  

  • 23. [Fluspirilen and fluphenazine in schizophrenic patients. Comparative study].
    Magnus RV
    MMW Munch Med Wochenschr; 1980 Dec; 122(49):1758-60. PubMed ID: 6779147
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-acting formulation leading to severe long-term adverse effects: a case report of fluphenazine and persistent extrapyramidal symptoms.
    Omi T; Mitsui Y; Matsunaga H
    J Clin Pharm Ther; 2018 Feb; 43(1):117-120. PubMed ID: 28718220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluphenazine pharmacokinetics and therapeutic response.
    Dysken MW; Javaid JI; Chang SS; Schaffer C; Shahid A; Davis JM
    Psychopharmacology (Berl); 1981; 73(3):205-10. PubMed ID: 6787637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mood elevating effect of trihexyphenidyl and biperiden in individuals taking antipsychotic medication.
    Jellinek T
    Dis Nerv Syst; 1977 May; 38(5):353-5. PubMed ID: 852367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effectiveness of parenteral administration of fluphenazine decanoate in the treatment of chronic schizophrenics.
    Kurland AA; Dim BH; Olsson JE
    Dis Nerv Syst; 1970 Sep; 31():Suppl:18-23. PubMed ID: 5476356
    [No Abstract]   [Full Text] [Related]  

  • 28. Fluphenazine-induced extrapyramidal side effects in a horse.
    Brashier M
    Vet Clin North Am Equine Pract; 2006 Apr; 22(1):e37-45. PubMed ID: 16627093
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-acting phenothiazine preparations in the treatment of schizophrenia.
    Kernohan GA
    Br J Psychiatry; 1972 Jan; 120(554):126-7. PubMed ID: 5041515
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapy with injectable fluphenazines.
    Ayd FJ
    Curr Psychiatr Ther; 1976; 16():177-89. PubMed ID: 991628
    [No Abstract]   [Full Text] [Related]  

  • 31. Depot fluphenazine: risk/benefit ratio.
    Glazer WM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients.
    Knights A; Okasha MS; Salih MA; Hirsch SR
    Br J Psychiatry; 1979 Dec; 135():515-23. PubMed ID: 394794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study of the delayed-action form of a synthetic antiparkinsonian drug: Akineton].
    Kammerer T; Schweitzer-Bucher E; Jamet P; Royer M
    Ann Med Psychol (Paris); 1972 May; 1(5):688-96. PubMed ID: 5081112
    [No Abstract]   [Full Text] [Related]  

  • 34. Practical considerations in the use of depot neuroleptics for the treatment of schizophrenia.
    Johnson DA
    Br J Hosp Med; 1977 Jun; 17(6):546-58. PubMed ID: 18242
    [No Abstract]   [Full Text] [Related]  

  • 35. The long-acting phenothiazines.
    Groves JE; Mandel MR
    Arch Gen Psychiatry; 1975 Jul; 32(7):893-900. PubMed ID: 239663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical-neuroleptic investigation of N-((1-ethyl-pyrrolidine-2-yl)-methyl)-2-methoxy-5-sulfamyl-benzamide-neuroleptic sulpiride (Dogmatil) in acutly ill schizophrenics].
    Haase HJ; Floru L; Ulrich F
    Int Pharmacopsychiatry; 1974; 9(2):77-94. PubMed ID: 4603413
    [No Abstract]   [Full Text] [Related]  

  • 37. Iatrogenic morbidity in patients taking depot fluphenazine.
    Jose C; Mallya A; Mehta D; Evenson R; Holland R
    Am J Psychiatry; 1979 Jul; 136(7):976-7. PubMed ID: 453363
    [No Abstract]   [Full Text] [Related]  

  • 38. A controlled one-year study of pipotiazine palmitate and fluphenazine decanoate in chronic schizophrenic syndromes. Evaluation of results at 6 and 12 months' trial.
    Dencker SJ; Frankenberg K; Malm U; Zell B
    Acta Psychiatr Scand Suppl; 1973; 241():101-18. PubMed ID: 4147508
    [No Abstract]   [Full Text] [Related]  

  • 39. [Rapid and megadose neuroleptic therapy. Critical review].
    de Girolamo G
    Minerva Psichiatr; 1985; 26(4):323-6. PubMed ID: 2869395
    [No Abstract]   [Full Text] [Related]  

  • 40. Tizanidine is not effective treating EPMS.
    Niederhofer H
    Med Hypotheses; 2018 Jul; 116():147. PubMed ID: 29857901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.